France Pulmonary Stents Market Size, Share, By Product (Self-expandable Stents and Balloon-expandable Stents), By Material (Metal, Silicon, Hybrid, and Others), By Type (Tracheobronchial Stents and Laryngeal Stents), France Pulmonary Stents Market Insights, Industry Trend, Forecasts to 2035

France Pulmonary Stents Market Insights Forecasts to 2035

• France Pulmonary Stents Market Size 2024 USD 7.48 Mn
• France Pulmonary Stents Market Size 2035  USD 13.47 Mn
• France Pulmonary Stents Market CAGR 2024 5.5%
• France Pulmonary Stents Market Segments Product, Material, and Type

The France pulmonary stents market is the segment of medical devices that are used to support or reopen the airways of patients who have blockages in their trachea, bronchus, or larynx. The market comprises self-expanding, silicone, and hybrid stents that are employed in hospitals and specialized respiratory care centers for the treatment of airway disorders and the enhancement of patient outcomes. The market expansion is powered by the prevalence of airway disorders worldwide, the increasing number of bronchoscopic minimally invasive procedures, the continuous innovations in self-expanding, silicone, and hybrid stents, and the trend of hospitals and specialized respiratory centers acquiring advanced stent technologies to both improve patient outcomes and ensure procedural safety.

France has a significant burden of patients with chronic respiratory diseases, such as COPD and asthma, and around 10 million individuals. The demand for pulmonary stents as part of advanced treatment strategies is obvious. The pulmonary stents market in France will expand as the number of minimally invasive procedures increases and chronic pulmonary conditions rise. The government of France facilitates medical device innovation by various funding programs like Soutien aux techniques innovantes coteuses (STIC), which in the past financed clinical research on innovative technologies, and also France 2030 initiatives that are committing €400 million specifically to promote innovative medical devices and technologies within the national health system. These investments are like fuel for the research of advanced stent technologies, clinical validation, and adoption.

Market Dynamics of the France Pulmonary Stents Market:

The France pulmonary stents market is driven by the increasing incidence rates of airway disorders, including bronchial and tracheal strictures, and increasing use of minimally invasive bronchoscopic procedures. Rapid advances in stent technology, an aging population, and improved hospital infrastructure across France will also drive increases in pulmonary stent market growth within France.

The France pulmonary stents market faces restraining factors such as the high costs for both the pulmonary stent devices and the procedures, possible complications (i.e., stent migration or infection), limited reimbursement in some instances for stents, and available alternative treatment methods to stenting, such as surgical options or pharmacologic therapies; these may hinder some patients from moving forward with treatment with a stent.

The future of the France pulmonary stents market is promising, with significant growth opportunities emerging from the rising prevalence of tracheobronchial and laryngeal disorders and technological advancements in stent design. The development of self-expanding, silicone, and hybrid stents, along with customized and 3D-printed airway stents, is improving patient outcomes and expanding clinical applications. Furthermore, integration of advanced imaging, navigation systems, and smart stent technologies is enhancing procedural efficiency, supporting wider hospital adoption, and meeting stringent regulatory standards.

Market Segmentation

The France Pulmonary Stents Market share is classified into product, material, and type.

By Product:

The France pulmonary stents market is divided by product into self-expandable stents and balloon-expandable stents. Among these, the self-expandable stents segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The self-expandable stents segment's growth is due to their flexibility, ease of deployment, and ability to conform to complex airway anatomies, which reduces the risk of migration and complications. Additionally, they are preferred in treating malignant and benign airway strictures, supporting wider clinical adoption in hospitals and specialized respiratory centers across France.

By Material:

The France pulmonary stents market is divided by material into metal, silicon, hybrid, and others. Among these, the metal segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The metal segment dominates because of its high radial strength, durability, and long-term patency, making it ideal for treating malignant and complex airway obstructions. Additionally, self-expanding metallic stents are widely preferred by clinicians for their ease of placement, supporting strong adoption in French hospitals and respiratory care centers.

By Type:

The France pulmonary stents market is divided by type into tracheobronchial stents and laryngeal stents. Among these, the tracheobronchial stents segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The tracheobronchial stents segment's growth is due to the high prevalence of tracheal and bronchial obstructions, increasing cases of lung cancer and airway strictures, and the rising adoption of minimally invasive bronchoscopic procedures. Their effectiveness in maintaining airway patency and improving patient breathing further drives demand in hospitals and specialized respiratory care centers across France.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France pulmonary stents market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in the France Pulmonary Stents Market

• Novatech SA
• EFER Endoscopy
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• Cook Medical
• Micro-Tech (Nanjing) Co., Ltd.
• Teleflex Incorporated
• Taewoong Medical Co., Ltd.
• Olympus Corporation
• ENDO-FLEX GmbH
• Others

Recent Developments in the France Pulmonary Stents Market

• December 2024: Micro-Tech Endoscopy highlighted its self-expanding airway stents, including tracheal/bronchial, Y-shaped, and J-shaped designs, which provide rapid relief from airway stenosis and improved breathing. These innovations support advanced pulmonary stent solutions available in markets such as France.

• September 2024: Abbott Laboratories (US) launched a new line of biodegradable lung stents designed to dissolve after fulfilling their intended purpose. This innovation addresses long-term foreign body complications and aligns with the growing demand for sustainable medical solutions.

Key Target Audience

• Market Players
• Investors
• End Users
• Government Authorities
• Consulting and Research Firms
• Venture Capitalists
• Value-Added Resellers (VARs)

Market Segmentation

This study forecasts revenue at the France national and regional levels from 2020 to 2035.Spherical Insights has segmented the France Pulmonary Stents Market based on the following categories:

France Pulmonary Stents Market, By Product

• Self-Expandable Stents
• Balloon-Expandable Stents

France Pulmonary Stents Market, By Material

• Metal
• Silicone
• Hybrid
• Others

France Pulmonary Stents Market, By Type

• Tracheobronchial Stents
• Laryngeal Stents